Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03168919Terminated
Open-label, single-arm trial, sponsored by University of Alabama at Birmingham. Primary endpoint: Changes of the Chemical Environment of the Tumor at 6 weeks. Started Oct 2016; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03168919.